{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:57:34Z","timestamp":1760266654213},"reference-count":37,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:p>BACKGROUND: Due to the risks related to long-term treatment with prednisone and azathioprine, most clinicians try to withdraw these drugs when patients with autoimmune hepatitis are in remission. However, there is a high probability of relapse, and most patients end up receiving maintenance treatment. AIM: To evaluate the safety and efficacy of maintenance treatment with chloroquine in the prevention of autoimmune hepatitis relapses. METHODS: Classical treatment was stopped after achievement of biochemical and histological remission of autoimmune hepatitis. Chloroquine diphosphate, 250 mg daily, was given for at least 12 months or until the occurrence of relapses defined by levels of aminotransferases at least twice the upper normal values. RESULTS: Fourteen patients were consecutively treated and compared with 18 historical controls. There was a 6.49 (1.38-30.30) greater chance of relapse in the historical controls when compared with patients treated with chloroquine (72.2% x 23.5%; 0.031). CONCLUSIONS: The group treated with chloroquine had a lower frequency of relapses. Chloroquine was safe in patients with autoimmune hepatitis and hepatic cirrhosis without decompensation, on 250 mg daily up to 2 years. These preliminary results provide a basis for upcoming controlled studies comparing chloroquine with placebo or for maintenance treatment with prednisone and\/or azathioprine for the prevention of autoimmune hepatitis relapses.<\/jats:p>","DOI":"10.1590\/s0004-28032005000400011","type":"journal-article","created":{"date-parts":[[2006,2,10]],"date-time":"2006-02-10T14:05:59Z","timestamp":1139580359000},"page":"249-255","source":"Crossref","is-referenced-by-count":11,"title":["Chloroquine for the maintenance of remission of autoimmune hepatitis: results of a pilot study"],"prefix":"10.1590","volume":"42","author":[{"given":"Marcos","family":"Mucenic","sequence":"first","affiliation":[{"name":"University of S\u00e3o Paulo School of Medicine, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evandro Sobroza de","family":"Mello","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo School of Medicine, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Luiz R.","family":"Can\u00e7ado","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo School of Medicine, Brazil; University of S\u00e3o Paulo School of Medicine, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez F","year":"1999","journal-title":"J Hepatol","ISSN":"http:\/\/id.crossref.org\/issn\/0168-8278","issn-type":"print"},{"key":"ref2","first-page":"73","article-title":"[Therapy of chronic hepatitis]","volume":"11","author":"Arnold W","year":"1981","journal-title":"Leber Magen Darm","ISSN":"http:\/\/id.crossref.org\/issn\/0300-8622","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres M","year":"2002","journal-title":"Gut","ISSN":"http:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis","volume":"33","author":"Ballot E","year":"2000","journal-title":"J Hepatol","ISSN":"http:\/\/id.crossref.org\/issn\/0168-8278","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","article-title":"Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2","volume":"94","author":"Bittencourt PL","year":"1999","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1399-0039.1996.tb02587.x","article-title":"Antigen processing and presentation","volume":"47","author":"Brodsky FM","year":"1996","journal-title":"Tissue Antigens","ISSN":"http:\/\/id.crossref.org\/issn\/0001-2815","issn-type":"print"},{"key":"ref7","first-page":"266","article-title":"Mild hepatitis probably caused by amodiaquine","volume":"80","author":"Charmot G","year":"1987","journal-title":"Bull Soc Pathol Exot Filiales","ISSN":"http:\/\/id.crossref.org\/issn\/0037-9085","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0016-5085(81)90126-8","article-title":"Laboratory Laboratory assessment assessment of of severe severe chronic chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features","volume":"80","author":"Czaja AJ","year":"1981","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/BF02088738","article-title":"Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis","volume":"41","author":"Czaja AJ","year":"1996","journal-title":"Dig Dis Sci","ISSN":"http:\/\/id.crossref.org\/issn\/0163-2116","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003495-199957010-00005","article-title":"Drug therapy in the management of type 1 autoimmune hepatitis","volume":"57","author":"Czaja AJ","year":"1999","journal-title":"Drugs","ISSN":"http:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja AJ","year":"2002","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","article-title":"Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis","volume":"35","author":"Czaja AJ","year":"2002","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref13","first-page":"658","article-title":"Therapy of chronic active hepatitis and Therapy of chronic active hepatitis and chloroquine compounds","volume":"60","author":"Doxiadis TA","year":"1971","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"s4","DOI":"10.1177\/096120339600500103","article-title":"Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development","volume":"5","author":"Fox R","year":"1996","journal-title":"Lupus","ISSN":"http:\/\/id.crossref.org\/issn\/0961-2033","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.15.3.251","article-title":"Chloroquine and rheumatoid arthritis: a short-term controlled trial","volume":"15","author":"Freedman A","year":"1956","journal-title":"Ann Rheum Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4967","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/ard.19.3.243","article-title":"Chloroquine in rheumatoid arthritis: a double blindfold trial of treatment for one-year","volume":"19","author":"Freedman A","year":"1960","journal-title":"Ann Rheum Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4967","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.1840030510","article-title":"Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis","volume":"3","author":"Hegarty JE","year":"1983","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref18","first-page":"759","article-title":"Reactivation of hepatitis B following withdrawal of chloroquine","volume":"124","author":"Helbling B","year":"1994","journal-title":"Schweiz Med Wochenschr","ISSN":"http:\/\/id.crossref.org\/issn\/0036-7672","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson PJ","year":"1995","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref20","first-page":"149","article-title":"Treatment of chronic active hepatitis B (CAH B) with Treatment of chronic active hepatitis B (CAH B) with chloroquine: a preliminary report","volume":"15","author":"Kouroumalis EA","year":"1986","journal-title":"Ann Acad Med Singapore","ISSN":"http:\/\/id.crossref.org\/issn\/0304-4602","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/jaut.1999.0304","article-title":"Towards the pathogenesis of autoimmune liver disease","volume":"13","author":"Mackay IR","year":"1999","journal-title":"J Autoimmun","ISSN":"http:\/\/id.crossref.org\/issn\/0896-8411","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns MP","year":"2001","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(79)92905-2","article-title":"Is chloroquine obsolete in treatment of rheumatic disease?","volume":"1","author":"Marks JS","year":"1979","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0167-5699(92)90123-O","article-title":"Intracellular transport of MHC class II molecules","volume":"13","author":"Neefjes JJ","year":"1992","journal-title":"Immunol Today","ISSN":"http:\/\/id.crossref.org\/issn\/0167-5699","issn-type":"print"},{"key":"ref25","series-title":"Cecil textbook of medicine","first-page":"1644","volume-title":"Rheumatoid arthritis","author":"O'Dell JR","year":"2004","edition":"22"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0190-9622(82)70002-7","article-title":"Antimalarials and ophthalmologic safety","volume":"6","author":"Olansky AJ","year":"1982","journal-title":"J Am Acad Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0190-9622","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0163-7258(97)00084-3","article-title":"4-Aminoquinolines - past, present and future: a chemical perspective","volume":"77","author":"O'Neill PM","year":"1998","journal-title":"Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0163-7258","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.20.1.18","article-title":"Chloroquine diphosphate in rheumatoid arthritis: a controlled trial","volume":"20","author":"Popert AJ","year":"1961","journal-title":"Ann Rheum Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4967","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-008X(89)90054-9","article-title":"A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs","volume":"97","author":"Reasor MJ","year":"1989","journal-title":"Toxicol Appl Pharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0041-008X","issn-type":"print"},{"issue":"Suppl","key":"ref30","first-page":"63","article-title":"Toxicity and side effects of antimalarials in Africa: a critical review","volume":"62","author":"Salako LA","year":"1984","journal-title":"Bull World Health Organ","ISSN":"http:\/\/id.crossref.org\/issn\/0042-9686","issn-type":"print"},{"key":"ref31","series-title":"Cecil textbook of medicine","first-page":"1660","volume-title":"Systemic lupus erythematosus","author":"Schur PH","year":"2004","edition":"22"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/10428199709039008","article-title":"The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially new therapy for graft-versus-host disease","volume":"24","author":"Schultz KR","year":"1997","journal-title":"Leuk Lymphoma","ISSN":"http:\/\/id.crossref.org\/issn\/1042-8194","issn-type":"print"},{"key":"ref33","first-page":"57","article-title":"Therapy of chronic hepatitis","volume":"39","author":"Siede W","year":"1979","journal-title":"Dtsch Z Verdau Stoffwechselkr","ISSN":"http:\/\/id.crossref.org\/issn\/0012-1053","issn-type":"print"},{"key":"ref34","first-page":"123","article-title":"Favorable efecto de la cloroquina sobre una hepatitis cr\u00f3nica subagresiva rebelde","volume":"45","author":"Sifre RB","year":"1975","journal-title":"Rev Esp Enf Ap Dig"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway RD","year":"1972","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.1840100110","article-title":"Extrahepatic malignancy following long-term immunosupressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis","volume":"10","author":"Wang KK","year":"1989","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref37","first-page":"456","article-title":"Treatment Treatment of of porphyria porphyria cutanea tarda with chloroquine and its effect on associated liver disease: retrospective analysis","volume":"124","author":"Wolff C","year":"1996","journal-title":"Rev Med Chil","ISSN":"http:\/\/id.crossref.org\/issn\/0034-9887","issn-type":"print"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v42n4\/27548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T16:20:57Z","timestamp":1586708457000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032005000400011&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0004-28032005000400011"],"URL":"https:\/\/doi.org\/10.1590\/s0004-28032005000400011","relation":{},"ISSN":["0004-2803"],"issn-type":[{"value":"0004-2803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}